Korea Joongang Daily
Korea JoongAng Daily

Celltrion to roll out record cash and stock dividends

Korean drugmaker Celltrion said Friday it will hand out its biggest-ever cash and stock dividends to its shareholders as part of efforts to boost shareholder value.

2024-12-13

CHA Meditech continues expansion in aesthetic medicine sector

CHA Meditech is turning to Brazil, a massive aesthetic medicine market, with its hyaluronic acid filler, HyaFilia.

2024-09-26

Global biotechnology exhibition opens in Seoul

A global biotechnology exhibition opened in Seoul on Wednesday with the aim of helping local businesses make inroads into the global market, officials said.

2024-07-10

CHA Bio, Boston's CIC to establish open innovation center for biotech ventures

CHA Bio Group will team up with Boston’s Cambridge Innovation Center to establish an open innovation center to attract biotech ventures worldwide at its cell and gene treatment manufacturing facility currently under construction in Pangyo, Gyeonggi.

2024-05-10

CHA Biotech signs material transfer deal with Chicago-based CanCure

CHA Biotech signed a material transfer deal with a U.S. biotech company to improve the efficacy of its natural killer cell-based cancer treatment.

2024-01-29

Orion Group to acquire stake in LegoChem Biosciences for $418 million

Confectionery firm Orion Group will acquire a 25.7 percent stake in LegoChem Biosciences for 550 billion won ($418 million), becoming the largest shareholder of the Kosdaq-listed biotech company.

2024-01-15

Korean biotech stocks surge after UK approves gene editing therapy

Biotech stocks in Korea surged after the UK approved a gene editing therapy developed by Vertex Pharmaceuticals and Crispr Therapeutics to treat blood disorders.

2023-11-17

U.S. subsidiary of CHA Biotech appoints new executives

Matica Biotechnology, a US subsidiary of CHA Biotech, has appointed Laura Parks as EVP of commercial operations and Heather Sugrue as VP of alliance management to enhance its cell and gene therapy contract manufacturing capabilities.

2023-09-19

Matica Biotechnology introduces self-developed cell line

Matica Biotechnology, a U.S. subsidiary of CHA Biotech, introduced its self-developed cell line MatiMax at the annual BIO International Convention 2023 (BIO USA) taking place in Boston.

2023-06-07

President Yoon calls for faster efforts to build global biotech cluster in Korea

President Yoon Suk Yeol instructed the government to speed along efforts to build a global biotech cluster in Korea inspired by the Boston hub in an export strategy meeting Thursday.

2023-06-01